RUTGERS, THE STATE UNIVERSITY

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Novel Gallium 68 Citrate in Orthopedic Infections

Phase 2

Terminated

Conditions: Joint Prosthesis

Interventions: Drug: 68-Gallium citrate PET/CT scan
Drug: 18F FDG PET/CT scan

First Posted Date: 2017-04-21

Last Posted Date: 2021-04-15

Lead Sponsor: Rutgers, The State University of New Jersey

Target Recruit Count: 1

Registration Number: NCT03123289

Locations: 🇺🇸
Rutgers New Jersey Medical School, Newark, New Jersey, United States

Dialectical Behavior Therapy Rutgers University Research Program

Not Applicable

Completed

Conditions: Borderline Personality Disorder

Interventions: Behavioral: Dialectical Behavior Therapy

First Posted Date: 2017-04-21

Last Posted Date: 2024-07-30

Lead Sponsor: Rutgers, The State University of New Jersey

Target Recruit Count: 145

Registration Number: NCT03123198

Locations: 🇺🇸
Rutgers University, Piscataway, New Jersey, United States

A Study of a Smartphone-based Intervention for Suicidal Inpatients

Not Applicable

Withdrawn

Conditions: Suicide, Attempted
Hopeless
Suicidal Ideation

Interventions: Behavioral: Treatment as Usual
Behavioral: Ecological Momentary Intervention

First Posted Date: 2017-04-20

Last Posted Date: 2024-05-29

Lead Sponsor: Rutgers, The State University of New Jersey

Registration Number: NCT03121742

Evaluation of a Visual Remediation Intervention for Schizophrenia

Not Applicable

Conditions: Schizophrenia

Interventions: Behavioral: Visual Training

First Posted Date: 2017-04-18

Last Posted Date: 2018-03-30

Lead Sponsor: Rutgers, The State University of New Jersey

Target Recruit Count: 40

Registration Number: NCT03117452

Locations: 🇺🇸
Rutgers University Behavioral Health Care (UBHC), Piscataway, New Jersey, United States

Novel Gallium Imaging in Hepatocellular Carcinoma

Phase 2

Conditions: Hepatocellular Carcinoma

Interventions: Drug: 68Gallium Citrate

First Posted Date: 2017-04-17

Last Posted Date: 2019-01-03

Lead Sponsor: Rutgers, The State University of New Jersey

Target Recruit Count: 18

Registration Number: NCT03116945

Locations: 🇺🇸
Rutgers New Jersey Medical School, Newark, New Jersey, United States

Therapeutic Epidural Patch Versus Pain Block in the Midface for Headache

Phase 3

Terminated

Conditions: Postdural Puncture Headache

Interventions: Device: Epidural Blood Patch
Drug: Sphenopalatine Ganglion Block

First Posted Date: 2017-04-13

Last Posted Date: 2023-06-22

Lead Sponsor: Rutgers, The State University of New Jersey

Target Recruit Count: 8

Registration Number: NCT03112720

Locations: 🇺🇸
New Jersey Pain Center, New Brunswick, New Jersey, United States
🇺🇸
RWJUH/Barnabus, New Brunswick, New Jersey, United States

Nerve Stimulator for Patients With Upper Extremity Disease, Vascular or Orthopedic Surgery

Not Applicable

Terminated

Conditions: Other Biomechanical Lesions of Upper Extremity

Interventions: Procedure: Local anesthetic block [0.35% marcaine]
Device: Braun DIG-R-C Stimuplex Blockade Monitor System

First Posted Date: 2017-04-13

Last Posted Date: 2024-03-05

Lead Sponsor: Rutgers, The State University of New Jersey

Target Recruit Count: 8

Registration Number: NCT03112642

Locations: 🇺🇸
Robert Wood Johnson University Hospital, New Brunswick, New Jersey, United States

Acceptance and Commitment Therapy in Improving Well-Being in Patients With Stage III-IV Cancer and Their Partners

Not Applicable

Completed

Conditions: Malignant Female Reproductive System Neoplasm
Stage IIIA Breast Cancer
Stage IIIA Colorectal Cancer
Stage IIIC Skin Melanoma
Stage IV Lung Cancer
Malignant Hepatobiliary Neoplasm
Stage III Colorectal Cancer
Stage IIIA Cervical Cancer
Stage IVA Uterine Corpus Cancer
Stage IVB Cervical Cancer

Interventions: Behavioral: Cognitive Behavior Therapy
Other: Quality-of-Life Assessment
Other: Questionnaire Administration
Other: Survey Administration

First Posted Date: 2017-04-13

Last Posted Date: 2021-04-08

Lead Sponsor: Rutgers, The State University of New Jersey

Target Recruit Count: 14

Registration Number: NCT03112668

Locations: 🇺🇸
Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, United States

Gluten Free Diet in Diminishing Side Effects Patients With Acute Myeloid Leukemia Undergoing Induction Chemotherapy

Phase 2

Terminated

Conditions: Acute Myeloid Leukemia

Interventions: Other: Best Practice
Other: Dietary Intervention
Procedure: Biospecimen Collection
Other: Laboratory Biomarker Analysis

First Posted Date: 2017-04-11

Last Posted Date: 2017-11-17

Lead Sponsor: Rutgers, The State University of New Jersey

Target Recruit Count: 1

Registration Number: NCT03108911

Locations: 🇺🇸
Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, United States

Gluten Free Diet in Preventing Graft Versus Host Disease in Patients Undergoing Donor Stem Cell Transplant

Not Applicable

Terminated

Conditions: Graft Versus Host Disease
Hematopoietic Cell Transplantation Recipient

Interventions: Other: Dietary Intervention
Other: Laboratory Biomarker Analysis

First Posted Date: 2017-04-05

Last Posted Date: 2021-08-23

Lead Sponsor: Rutgers, The State University of New Jersey

Target Recruit Count: 7

Registration Number: NCT03102060

Locations: 🇺🇸
Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, United States

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy